Chemours (NYSE:CC) is preparing to appoint the chief executive of Vision One Management Partners to its board in an effort to ...

Chemours Co. plans to add the chief executive officer of Vision One Management Partners to its board as it seeks to avoid a ...

Opteon™ 2P50, Chemours’ developmental dielectric thermal management fluid, has an ultra-low global warming potential of 10 ...

Company announced the launch of a full-scale product trial with NTT Data and a regional engineering firm, Hibiya Engineering, ...

Chemours joins forces with NTT DATA and Hibiya Engineering, Ltd. to advance data center two-phase immersion cooling with ...

Chemours is expanding sampling eligibility to additional homes inside and neighboring southeastern North Carolina at the ...

The N.C. Department of Environmental Quality is continuing Chemours’ search for groundwater contamination beyond the Lower ...

The Chemours Company (NYSE:CC – Get Free Report) has received an average recommendation of “Hold” from the nine ratings firms that are presently covering the company, Marketbeat Ratings reports.

North Carolina ordered Chemours to expand PFAS well testing, adding 150,000 homes in six counties, including Harnett and Hoke ...

Barclays analyst Michael Leithead maintained a Hold rating on Chemours Company (CC – Research Report) today and set a price target of $19.00.

“We are pleased to partner with Chemours and the broader data center value chain to accelerate the practical application of liquid and immersion cooling technologies through this field trial ...

It is unclear what actions the Trump administration will take, if any, to protect the public against PFAS, linked to cancer and other health problems.